Financhill
Buy
59

LMB Quote, Financials, Valuation and Earnings

Last price:
$79.48
Seasonality move :
5.08%
Day range:
$79.44 - $81.10
52-week range:
$63.02 - $154.05
Dividend yield:
0%
P/E ratio:
26.26x
P/S ratio:
1.59x
P/B ratio:
5.10x
Volume:
53.6K
Avg. volume:
168.9K
1-year change:
-9.59%
Market cap:
$925.1M
Revenue:
$518.8M
EPS (TTM):
$3.03

LMB Analysts' Consensus Rating

The 3 analysts providing 12-month price projections for Limbach Holdings, Inc. shares anticipate an average target of $124.25, ranging from a low estimate of $111.00 to a high estimate of $156.00. This average target implies a growth of 56.15% compared to the current stock price of $79.57.

Consensus Price Target

$124.25

Highest Price Target

$156.00

Lowest Price Target

$111.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 3 3 3

Hold 0 0 0

Sell 0 0 0
Consensus Buy Buy Buy

LMB Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock